<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Respiratory syncytial virus (RSV) is responsible for lower respiratory tract infections across all age groups worldwide. Initial exposure to RSV in infants and young children can lead to severe bronchiolitis, which has the potential to be life-threatening. Among older children and healthy adults, recurrent upper respiratory tract infections caused by RSV are frequent, varying in intensity from asymptomatic infection to symptomatic upper respiratory tract disease. The presence of specific comorbidities (cardiopulmonary conditions, including COPD and CHF, and immunocompromising conditions) increases the likelihood of severe disease in adults (<xref ref-type="bibr" rid="j_pneum-2023-0046_ref_001">1</xref>).</p>
<p>This editorial provides a review of the burden of RSV disease among adults, population groups at increased risk of developing severe RSV disease, the current status of surveillance systems and RSV prevention strategies in adults, including the use of RSV vaccines in adults, recently licensed for use.</p>
</abstract>

Respiratory syncytial virus (RSV) is responsible for lower respiratory tract infections across all age groups worldwide. Initial exposure to RSV in infants and young children can lead to severe bronchiolitis, which has the potential to be life-threatening. Among older children and healthy adults, recurrent upper respiratory tract infections caused by RSV are frequent, varying in intensity from asymptomatic infection to symptomatic upper respiratory tract disease. The presence of specific comorbidities (cardiopulmonary conditions, including COPD and CHF, and immunocompromising conditions) increases the likelihood of severe disease in adults (1).
This editorial provides a review of the burden of RSV disease among adults, population groups at increased risk of developing severe RSV disease, the current status of surveillance systems and RSV prevention strategies in adults, including the use of RSV vaccines in adults, recently licensed for use.

RSV Burden of Disease in Adults - a new threat

Pneumologia

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Virusul Sincițial Respirator la adulți - o nouă amenințare

Respiratory syncytial virus (RSV) is responsible for lower respiratory tract infections across all age groups worldwide. Initial exposure to RSV in infants and...

RSV Burden of Disease in Adults - a new threat

Article Category: Editorial

Data publikacji: 02 maj 2024

Zakres stron: 195 - 201

DOI: https://doi.org/10.2478/pneum-2023-0046

Słowa kluczowe
respiratory syncytial virus, RSV, RSVpreF

© 2022 Florin Mihaltan et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

RSV Burden of Disease in Adults - a new threat

Article Category: Editorial

Data publikacji: 02 maj 2024

Zakres stron: 195 - 201

DOI: https://doi.org/10.2478/pneum-2023-0046

Słowa kluczowerespiratory syncytial virus, RSV, RSVpreF

© 2022 Florin Mihaltan et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Słowa kluczowe
respiratory syncytial virus, RSV, RSVpreF